相关实验视频

Updated: May 23, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

针对质母细胞瘤中的EGFR和PI3K/mTOR通路:创新的治疗方法

Gursimran Singh¹, Rohit², Pankaj Kumar³

¹Department of Pharmacy Practice, ISF College of Pharmacy (an Autonomous College), Moga, Punjab, 142001, India.

Medical oncology (Northwood, London, England)

|March 11, 2025

概括

质母细胞瘤 (GBM) 是一种侵袭性脑癌,由表皮生长因子受体 (EGFR) 和PI3K/AKT/mTOR通路驱动. 针对这些途径为改善质母细胞瘤治疗提供了新的希望.

科学领域:

神经瘤学神经瘤学
分子生物学分子生物学
癌症研究癌症研究

背景情况:

质母细胞瘤 (GBM) 是成年人中最具攻击性的原发性脑癌.
GBM的特点是快速生长,入侵和血管生成.
表皮生长因子受体 (EGFR) 的过度表达和突变在GBM中很常见.

研究的目的:

探索GBM的分子基础,重点关注EGFR和PI3K/mTOR途径.
在临床和临床前试验中审查当前的EGFR和PI3K/AKT/mTOR抑制剂.
为应对治疗耐药性和GBM未来治疗方向的挑战.

主要方法:

关于GBM分子机制的文献综述.
信号通路的分析,包括EGFR/PTEN/AKT/mTOR.
检查当前和新兴的治疗抑制剂.

主要成果:

EGFR信号传递驱动GBM瘤的发生,增殖和生存.
在GBM中,PI3K/AKT/mTOR通路经常受到失调.
在PTEN中异常是常见的,影响瘤抑制.
针对EGFR和PI3K/AKT/mTOR通路的抑制剂显示出治疗潜力.

结论:

了解EGFR和PI3K/mTOR通路对于GBM治疗至关重要.
向疗法提供了希望,但面临挑战,如抵抗.
对于GBM,需要对新型抑制剂和组合策略进行进一步的研究.

关键词:

血管新生的产生.欧洲农业基金会 (EGRF) 是一个欧洲农业基金.质母细胞瘤 (glioblastoma) 是一个在 MTOR 中,我们可以使用 MTOR.在PI3K中,PI3K是指PI3K.在这里,我们可以看到PTEN.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.